Drug Pipeline

Povorcitinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
9
Active Studies
4
Recruiting
6
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-29 NCT06516952
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With…
overall status: "Recruiting" → "Active Not Recruiting"
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-14 NCT07588139 A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of… Phase 1 Recruiting
Active Studies by Phase
Phase 3
6
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06855498 Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib Hidradenitis Suppurativa (HS) Recruiting
NCT06113445 A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental… NonSegmental Vitiligo Active, Not Recruiting
NCT06212999 A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants… Hidradenitis Suppurativa (HS) Active, Not Recruiting
NCT06113471 A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental… NonSegmental Vitiligo Active, Not Recruiting
NCT06516965 A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… Prurigo Nodularis Active, Not Recruiting
NCT06516952 A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… Prurigo Nodularis Active, Not Recruiting
Phase 2
NCT05851443 A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… Moderate to Severe Asthma Recruiting
NCT07213973 Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With… Hidradenitis Suppurativa (HS) Recruiting
Phase 1
NCT07588139 A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of… Healthy Participants Recruiting
Sponsors Running Povorcitinib Trials
Disease Areas
Get alerts when Povorcitinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free